Eugene

[email protected]

LATEST

Merck KGaA Partners in Digital Health for Diabetes
By

By
Merck KGaA has partnered with Blue Mesa Health, a New York-headquartered digital therapeutics company, to pilot Blue Mesa’s diabetes-prevention programs in territories outside of the US. Blue Mesa Health has…

BI US CEO To Retire; New President, CEO Appointed
By

By
Boehringer Ingelheim’s (BI) US President and Chief Executive Officer (CEO), Paul Fonteyne, plans to retire after 15 years of service on December 31, 2018. Wolfgang Baiker, MD, PhD, MBA, currently…

Eisai Partners for Alzheimer’s Disease
By

By
Eisai and the Boston University School of Medicine have formed a research collaboration to study the effects of Alzheimer’s disease (AD)-associated genetic variants on the behavior of brain cells, called…

AstraZeneca, Syndax in Cancer Clinical Trial Pact
By

By
AstraZeneca and Syndax Pharmaceuticals, a Waltham, Massachusetts-headquartered clinical-stage biopharmaceutical company developing cancer therapies, have formed a clinical pact to evaluate AstraZeneca’s durvalumab, a human monoclonal antibody directed against programmed death-ligand…

BI, Prime Therapeutics in Outcome-Based Contract for Diabetes Drug
By

By
Boehringer Ingelheim (BI) has signed an outcomes-based contract with Prime Therapeutics, an Eagan, Minnesota-headquartered pharmacy benefit manager (PBM), for Jardiance (empagliflozin), a drug for treating Type II diabetes. The drug…

Sanofi Sells Mfg Facility to Partner Therapeutics
By

By
Sanofi has sold global rights to develop, manufacture, and commercialize Leukine (sargramostim), an immuno-stimulant drug, to Partner Therapeutics (PTx), a Boston, Massachusetts-based biopharmaceutical company focused on cancer, and sold a…

Pfizer, AbbVie Plan US Capital Investments
By

By
Pfizer and AbbVie have announced near-term capital-allocation plans, including increased investment for manufacturing projects in the US. The companies made the announcements in their full-year and fourth quarter 2017 earnings…

Amneal Pharmaceuticals To Expand Solid Dose Mfg Facility
By

By
Amneal Pharmaceuticals, a Bridgewater, New Jersey-based generic-drug manufacturer, plans to expand its manufacturing plant in Long Island, New York for solid dose and softgel products.   The company plans to…

President Trump Addresses Drug Pricing in State of the Union Address
By

By
During his State of the Union address, President Donald Trump addressed several policy issues relating to healthcare, including lowering prescription drug costs and improving access to investigational drugs. “One of…

JP Morgan, Berkshire Hathaway, and Amazon Form Healthcare Company
By

By
Offering a new business model in healthcare, JPMorgan Chase & Co., Berkshire Hathaway, and Amazon have partnered to form a new healthcare company to provide healthcare for their US employees…